Bionime Corporation
Research Bionime Corporation (4737.TW) on Bullrun: market cap TWD 4.37B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker4737.TW
- ExchangeTW
- CountryTaiwan
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyTWD
- Market capTWD 4.37B
- Financial periodQ2 2026
- RevenueTWD 426.63M
- Net income-TWD 53.44M
- Free cash flow-TWD 102.56M
- Gross margin37.3%
Valuation Snapshot
latest market cap is TWD 4.37B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | TWD 4.37B | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 TWD.
About Bionime Corporation
Bionime Corporation designs, manufactures, and sells medical instruments in China, Switzerland, the United States, Belarus, Algeria, the United Arab Emirates, Egypt, and internationally. The company manufactures and sells blood glucose meters and test strips to medical equipment companies, pharmacies, and hospitals, as well as offering blood glucose monitoring devices and systems under the RIGHTEST brand; a continuous glucose monitoring system under the iFree CGM brand; and medical blood glucose management systems.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Bionime Corporation's market cap?
Bionime Corporation's market capitalization is TWD 4.37B.
What does Bionime Corporation do?
Bionime Corporation designs, manufactures, and sells medical instruments in China, Switzerland, the United States, Belarus, Algeria, the United Arab Emirates, Egypt, and internationally. The company manufactures and sells blood glucose meters and test strips to medical equipment companies, pharmacies, and hospitals, as well as offering blood glucose monitoring devices and systems under the RIGHTEST brand; a continuous glucose monitoring system under the iFree CGM brand; and medical blood glucose management systems.